Metformin may reduce Alzheimer’s disease risk by increasing soluble amyloid-β42 levels

Authors

Institutions

Publication Details

Journal
Brain
Published
2024-11-08
DOI
https://doi.org/10.1093/brain/awae367
Citations
6
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
1.96

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metformin may reduce Alzheimer’s disease risk by increasing soluble amyloid-β42 levels

Bruno Pietro Imbimbo, Timothy P Daly
6 citations
Brain
Alzheimer's disease research and treatments
1.96
article

Metformin may reduce Alzheimer’s disease risk by increasing soluble amyloid-β42 levels

Bruno Pietro Imbimbo, Timothy P Daly
article en
6 citations

Abstract

No abstract available for this paper.
BrainVol. 148(3)
Centre National de la Recherche Scientifique (FR), Université de Bordeaux (FR), Inserm (FR), Facultad Latinoamericana de Ciencias Sociales Sede Argentina (AR), Bordeaux Population Health (FR), Immunology from Concept and Experiments to Translation (FR), Chiesi Foundation (IT), Chiesi (Italy) (IT), Chiesi (France) (FR)
Institut National de la Santé et de la Recherche Médicale
Good health and well-being
Openalex Percentile: Top 13%
Alzheimer's disease research and treatments
1.96
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.